Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT04927481 |
| Consolidated Lead Sponsor | CSPC ZhongQi Pharmaceutical Technology Co |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | TERMINATED |
| Registered Enrollment | 28 participants (ACTUAL) |
| Registered Start Date | 2021-06-11 |
| WhyStopped Classification | Unspecified |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Affiliated Hospital of Hebei University | Baoding, China | Open Hospital Dossier -> |
| The Fourth Hospital of Hebei Medical University | Shijiazhuang, China | Open Hospital Dossier -> |
| Harbin Medical University Cancer Hospital | Harbin, China | Open Hospital Dossier -> |
| The first affiliated hospital of Zhengzhou University | Zhengzhou, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.